Vortioxetine Hydrobromide Tablets Uses
There are four specifications for vortioxetine: 5mg, 10mg, 15mg, 20mg. Vortioxetine hydrobromide is considered to be a new multi-model antidepressant drug. In vitro studies have shown that it can antagonize 5-HT3, 5-HT7 and 5-HT1D receptors, activate 5-HT1A receptors, and partially activate 5- HT1B receptor and inhibit 5-HT transport.Vortioxetine hydrobromide is a new type of bisarylsulfanylamine antidepressant jointly developed by Takeda Japan and Lingbei, Denmark. It is used in the treatment of depression and anxiety.
| Items | Standards | Results |
| Appearance | White to light-yellow solid | Complies |
| Identification | By IR | Complies |
| By HPLC | Complies | |
| Loss on Drying | ≤0.50% | 0.30% |
| Heavy Metals | ≤20ppm | Complies |
| Residue on Ignition | ≤0.10% | 0.04% |
| Related Substances | Maximum single impurity: ≤0.10% | 0.05% |
| Total Impurities: ≤1.00% | 0.08% | |
| Assay (HPLC basis on drying) | 98.0%~102.0% | 99.93% |
| Reference Standard | In-house Standard | |
| Conclusion | The product complied to In-house standard. | |
| Storage | Preserve in tight,light-resistant containers in a cool place | |
Product Categories : Vortioxetine Hydrobromide
Tel: 86-0531-13361072018
Mobile Phone: +8613361072018
Website: https://www.cnsrtrade.com
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Contact Now